Inhibition of Proliferation in U937 Cells Treated by Blue Light Irradiation and Combined Blue Light Irradiation/Drug

International Journal of Molecular Sciences
Jianjian ZhuangHongdong Li

Abstract

The cell viability and apoptosis of tumor U937 cells treated by blue light (BL) irradiation have been examined. BL irradiation can specially inhibit the proliferation and promote the apoptosis of U937 cells, relating to the production of reactive oxygen species (ROS) and the decline of mitochondrial membrane potential (ΔΨm). The apoptosis is further associated with varying downregulated B-cell lymphoma-extra large (Bcl-XL) and B-cell lymphoma 2 (Bcl-2) genes, upregulated Bcl-2-associated X (Bax) gene, the activation of caspase-3 and caspase-9, and the cleavage of poly (ADP-ribose) polymerase (PARP) by the BL irradiation process. Moreover, BL irradiation induced proliferation inhibition is higher than that treated by a common chemotherapeutic drug of homoharringtonine (HHT). When we synergize BL irradiation with HHT (BL-HHT), a higher proliferation inhibition is obtained than that treated by BL irradiation or HHT alone. These results are helpful for establishing a low toxicity and high efficiency strategy of BL irradiation for clinical treatment of acute myeloid leukemia, not limited to U937 cells.

References

May 15, 1976·International Journal of Cancer. Journal International Du Cancer·C Sundström, K Nilsson
May 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R P WarrellT S Gee
Jan 1, 1985·Investigational New Drugs·J A Stewart, I H Krakoff
Aug 1, 1983·The Journal of Pediatrics·J F EnneverW T Speck
Apr 2, 1998·European Journal of Biochemistry·B Mignotte, J L Vayssiere
Jun 24, 1998·Journal of the National Cancer Institute·T J DoughertyQ Peng
Aug 13, 1999·Genes & Development·A GrossS J Korsmeyer
May 31, 2002·Japanese Journal of Cancer Research : Gann·Masayuki OharaHiromitsu Watanabe
Aug 27, 2002·Annual Review of Genomics and Human Genetics·Louise M Kelly, D Gary Gilliland
May 6, 2003·Biochemical and Biophysical Research Communications·Guido Kroemer
Jul 9, 2004·Cancer·Norbert VeyDominique Maraninchi
May 19, 2006·Photomedicine and Laser Surgery·Rachel LubartShimon Rochkind
Nov 23, 2006·Journal of Environmental Science and Health. Part A, Toxic/hazardous Substances & Environmental Engineering·Hueiwang Anna Jeng, James Swanson
Jul 7, 2007·Leukemia & Lymphoma·Yin-Jun LouJie Jin
Jan 1, 2014·Recent Patents on Endocrine, Metabolic & Immune Drug Discovery·Emilio J Sanchez-Barcelo, Maria D Mediavilla
Jun 6, 2015·Dermatology : International Journal for Clinical and Investigative Dermatology·Stephanie PfaffVerena von Felbert
Nov 12, 2015·The International Journal of Biochemistry & Cell Biology·Phil-Sun OhHwan-Jeong Jeong
Apr 22, 2016·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·S L HopkinsSylvestre Bonnet

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
flow cytometry
PCR
Polymerase Chain Reaction
Protein Assay

Software Mentioned

GraphPad Prism
Cell Quest
Image Lab

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.